Josephine van Dongen

Chapter 1 22 68. de Bree LCJ, Koeken VACM, Joosten LAB, et al. Non-specific effects of vaccines: Cur- rent evidence and potential implications. Semin Immunol. 2018;39(April):35-43. doi:10.1016/j. smim.2018.06.002 69. Rogers MAM, Basu T, Kim C. Lower Incidence Rate of Type 1 Diabetes after Receipt of the Rotavirus Vaccine in the United States, 2001–2017. Sci Rep . 2019;9(1):7727. doi:10.1038/s41598-019- 44193-4 70. Monk HM, Motsney AJ,Wade KC. Safety of Rotavirus Vaccine in the NICU. Pediatrics . 2014;133(6):e1555-e1560. doi:10.1542/peds.2013-3504 71. Van der Wielen M,Van Damme P. Pentavalent human-bovine (WC3) reassortant rotavirus vaccine in special populations: A review of data from the Rotavirus Efficacy and Safety Trial. Eur J Clin Microbiol Infect Dis. 2008;27(7):495-501. doi:10.1007/s10096-008-0479-5 72. Bines JE, Patel M, Parashar U. Assessment of Postlicensure Safety of Rotavirus Vaccines, with Emphasis on Intussusception. J Infect Dis. 2009;200. doi:10.1086/605051 73. Kassim P, Eslick GD. Risk of intussusception following rotavirus vaccination: An evidence based meta-analysis of cohor t and case-control studies. Vaccine . 2017;35(33):4276-4286. doi:10.1016/j.vac- cine.2017.05.064 74. Koch J, Harder T, von Kries R,Wichmann O. Risk of Intussusception After Rotavirus Vaccination. Dtsch Aerzteblatt Online. 2017;114:255-262. doi:10.3238/arztebl.2017.0255 75. Payne DC, Edwards KM, Bowen MD, et al. Sibling Transmission of Vaccine-Derived Rotavirus (RotaTeq) AssociatedWith Rotavirus Gastroenteritis. Pediatrics . 2010;125(2). Accessed August 9, 2017. http://pediatrics.aappublications.org/content/125/2/e438 76. Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis. 2008;8(10):642-649. doi:10.1016/S1473-3099(08)70231-7 77. Kaplon J, Cros G, Amber t-Balay K, et al. Rotavirus Vaccine Virus Shedding,Viremia an Clearance in Infants with Severe Combined Immune Deficiency. Pediatr Infect Dis J . 2015;34(3):326-328. 78. Sakon N, Miyamoto R, Komano J, Pediatr EJ. An infant with acute gastroenteritis caused by a secondary infection with a Rotarix-derived strain . Eur J Pediatr. Published online 2017. doi:10.1007/ s00431-017-2963-3 79. Smith CK, McNeal MM, Meyer NR, Haase S, Dekker CL. Rotavirus shedding in premature infants following first immunization. Vaccine. 2011;29:8141-8146. doi:10.1016/j.vaccine.2011.08.028 80. Ladhani SN, Ramsay ME.Timely immunisation of premature infants against rotavirus in the neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed. 2014;99(6):F445-F447. doi:10.1136/ archdischild-2013-305744 81. Weekly epidemiological record Relevé épidémiologique hebdomadaire. 2018;(1):1-8. 82. Toenders WGM. CFH-Rappor t Beoordeling Rotavirus RIX4414 (Rotarix).Vol 3.; 2007. 83. Gezondheidsraad (Health Council of the Netherlands). De Toekomst van Het Rijksvaccinatie- programma: Naar Een Programma Voor Alle Leeftijden.; 2007. 84. Gezondheidsraad (Health Council of the Netherlands). Het individuele, collectieve en pub- lieke belang van vaccinatie. Published online 2013:1-86. 85. Tešović G. Childhood vaccinations in Croatia. Period Biol. 2012;114(2):149-166. 86. ECDC. Rotavirus infection: Recommended vaccination schedule. ECDC. Published 2021. Accessed February 24, 2021. https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDis- easeId=32&SelectedCountryIdByDisease=-1 87. Bruijning-Verhagen PCJ. RIVAR study protocol. Published 2014. Accessed November 17, 2020. https://www.trialregister.nl/trial/5213